SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
T-cell prolymphocytic leukemia (T-PLL) is an aggressive malignancy with a median survival of the patients of less than two years. Besides characteristic chromosomal translocations, frequent mutations affect the ATM gene, JAK/STAT pathway members, and epigenetic regulators. We here performed a targeted mutation analysis for 40 genes selected from a RNA sequencing of 10 T-PLL in a collection of 28 T-PLL, and an exome analysis of five further cases. Nonsynonymous mutations were identified in 30 of the 40 genes, 18 being recurrently mutated. We identified recurrently mutated genes previously unknown to be mutated in T-PLL, which are SAMHD1, HERC1, HERC2, PRDM2, PARP10, PTPRC, and FOXP1. SAMHD1 regulates cellular deoxynucleotide levels and acts as a potential tumor suppressor in other leukemias. We observed destructive mutations in 18% of cases as well as deletions in two further cases. Taken together, we identified additional genes involved in JAK/STAT signaling (PTPRC), epigenetic regulation (PRDM2), or DNA damage repair (SAMHD1, PARP10, HERC1, and HERC2) as being recurrently mutated in T-PLL. Thus, our study considerably extends the picture of pathways involved in molecular pathogenesis of T-PLL and identifies the tumor suppressor gene SAMHD1 with ~20% of T-PLL affected by destructive lesions likely as major player in T-PLL pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Mouradov, D., Sloggett, C., Jorissen, R. N., Love, C. G., Li, S., Burgess, A. W., Arango, D., Strausberg, R. L., Buchanan, D., Wormald, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0013 · Cited by 375
Cited by
Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
Braun, T., Stachelscheid, J., Bley, N., Oberbeck, S., Otte, M., Müller, T. A., Wahnschaffe, L., Glaß, M., Ommer, K., Franitza, M., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1908 · Cited by 14
Braun, T., Stachelscheid, J., Bley, N., Oberbeck, S., Otte, M., Müller, T. A., Wahnschaffe, L., Glaß, M., Ommer, K., Franitza, M., et al. (2023) · doi:10.1158/0008-5472.c.6513796
(2023) · doi:10.1158/0008-5472.c.6513796.v1
Metadata
- Authors
- Johansson, P., Klein-Hitpass, L., Choidas, A., Habenberger, P., Mahboubi, B., Kim, B., Bergmann, A., Scholtysik, R., Brauser, M., Lollies, A., Siebert, R., Zenz, T., Dührsen, U., Küppers, R., & Dürig, J.
- Venue
- Blood Cancer Journal
- Published
- 2018-01-19
- Volume
- 8
- Issue
- 1
- Pages
- 11-11
- ISSN
- 2044-5385 (ISSN-L)
- OpenAlex
- W2788786197
- Cited by
- 66
- References
- 2
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia. https://app.cochat.ai/papers/10.1038/s41408-017-0036-5
- The paper
- Johansson, P., Klein-Hitpass, L., Choidas, A., Habenberger, P., Mahboubi, B., Kim, B., Bergmann, A., Scholtysik, R., Brauser, M., Lollies, A., Siebert, R., Zenz, T., Dührsen, U., Küppers, R., & Dürig, J. (2018). SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia. Blood Cancer Journal. https://doi.org/10.1038/s41408-017-0036-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.